Header Ads

Label

addiction (9) alcohol (9) arthritis (6) body (9) carbohydrates (6) diet (12) drug (9) Expertise (1) fat (8) health (9) insurance (4) loss (13) low-carb (9) medical (1) medication (6) pain (5) Private (2) relief (6) remedy (4) selfemployed (1) slim (4) symptom (7) tips (5) treatment (15) weight (11)
Tampilkan postingan dengan label symptom. Tampilkan semua postingan
Tampilkan postingan dengan label symptom. Tampilkan semua postingan

Tibiofemoral osteoarthritis, diagnosis

Written By Hendrafa on Sabtu, 09 Februari 2013 | 10.14

Osteoarthritis of the knee (OAK) is the most common presentation is the participation in the joint, the tibiofemoral (part) of the femur and tibia (the larger of the two lower leg bones).

These are the two areas that contain the hyaline cartilage within a generation, most of the time.

As mentioned above, the hyaline cartilage is "more difficult" in the course of the two types of cartilage in the knee. Hyaline cartilage caps the long bones contain, at the same time, the joint, the ends of the Fibrocartilage, softer taped to the cartilage of the knee menisci, medial and represents. These are the semicircular piece of cartilage, hyaline cartilage that provides certainty, when it comes, the flying and rotate.

The symptoms usually consists of OAK, the joint stiffness, swelling, and tenderness of the joint fluid buildup along a line. Over time, as well as the ability to bend and straighten knee weakens. Even if one of the title, either in the form of a knee medial (inside) and lateral (outside) of the passenger compartment can be affected more than others, often in the two sections. This causes the diffuse pain.

Diagnosis is suspected clinically the history and physical examination. It may be determined in accordance with the standing knee x-ray is reflected in the positive changes. Magnetic resonance imaging (MRI) is substantially more sensitive description of the changes to the TOS, which is made up of cartilage defects, bone edema (swelling), and fluid.

A typical treatment program with the aim of reducing pain and function.

If the patient is overweight, weight is necessary. Regular exercise, aerobic exercise, which consist of low-resistance exercise and stretching are patient with the OAK of the mind-the parts of the program.

Non-steroidal-anti-signs of the drug orally, or, if it is to be carried out by the agent, in addition to the current may also be used.

Excessive joint fluid capital glucocorticoids ("Cortisone") follows from the burden of relief are useful. Glucocorticoids deleterious effect on the cartilage and should be used sparingly, more than three times a year for a joint.

The patient may also benefit from the contributions of capital viscosupplement. These are substances that are made up of hyaluronic acid, which mimics Normal joint fluid properties. These capital contributions may also help the relief of burden of proof.

All of the capital contributions required to be administered by applying ultrasound to ensure the accuracy of the control.

Surgery as defined in the cartilage or cartilage Sparing Table. Cartilage sparing procedures to join the osteotomy wedge of bone from the line-in order to get a straighter edge the knee joint. This is used for active young people to buy time. The cartilage of the joint replacement procedures, refer to the "top sacrificing. The trend has recently obtained the younger patients. The downside is that these surgeries are associated with serious complications including infection, monitor, and a small but real risk of death.

This option is shown as an alternative to the patient's own blood stem cells, the stem cells help maintain and regrow knee cartilage may have osteoarthritis.

(Wei, et al. Guided Mesenchymal stem cells for the treatment of osteoarthritis of the knee layering Technique. (J) shall apply to the Res. 2011; 11: 44-48)

Nathan Wei, MD, FACP, FACR is a rheumatologist and the arthritis treatment Center-http://www.arthritistreatmentcenter.com/. He is a former Assistant Professor of medicine, University of Maryland, University of, school of medicine and consultant to the health of the plants. For more information: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html.


View the original article here

10.14 | 0 komentar | Read More

the normal approach to the treatment of osteoarthritis

Written By Hendrafa on Jumat, 08 Februari 2013 | 14.41

Osteoarthritis (OA) is the most common type of arthritis, without question. It is the cartilage that caps the ends of the long bones and gristle. The cartilage is made up of proteins and sugars (proteoglycans) and collagen. This array of substances, the cartilage cells to chondrocytes are interspersed. Chondrocytes to produce an array of healthy and keep healthy.

OA insolvency chondrocytes from destructive enzymes to produce. In addition, it is the interaction events complex, which leads to the hardening of the bones with bone formation and on the basis of the pace of the synovium (joint) inflammation, which causes the destruction of the joint.

OA is the weight-bearing joints, disease-. However, the other can affect the joints and causes the symptoms and loss of function in the can.

The normal approach to osteoarthritis has not changed for more than fifty years.

For the treatment of the three, the aim is to release the symptoms, improve function and returns the value of the cartilage. But in some cases, the achievement of the objectives of the former two, the latter has remained elusive.

OA treatment begins with a non-medical measures, such as weight, physical therapy, exercise, training, and in some cases, the assistive technology products are available for patients. Assistive devices, such as braces and canes that may help the patient perform activities of daily living more efficiently.

Many of the doctors Advocate General pain (pain relievers) instead of the traditional-steroidal anti-inflammatory drug (NSAID). This is the heart of the events and the use of drugs for medicinal products in relation to the events in the tract on the basis of data relating to the latter group, the side effect profile.

One way to work around this is to use a NSAID topical form. Two products, Voltaren gel and Pennsaid, which are topical anti-inflammatory drug Diclofenac medicated.

Nutriceuticals such as Glucosamine and chondroitin is their support. In addition, various surveys, touting the benefits of the diet fish oil and herbal remedies, these are also the people with mild OA option. Glucocorticoid in patients with significant problems in the capital can be employed. They may be administered using ultrasound guidance and no more than three times per year per individual.

Viscosupplements, lubricants, can also be used, even if they are marked with the, so far, only knee OA. With glucocorticoids, they must be managed using ultrasound guidance, to ensure the proper placement.

Is a huge void of these conservative therapies and surgery.

In the case of an autologous growth factors, such as the recent experience of thrombocyte RICH plasma (PRP) by using their own blood stem cells, as well as (the patient's stem cells) can be cartilage and cartilage regeneration of the promise.

(Wei, Beard S, S, C, Gillis Delauter Bitner, R L, Miller C, Rau Clark T guided Mesenchymal stem cells for the treatment of osteoarthritis of the knee layering Technique. (J) shall apply to the Res. 2011; 11: 44-48)

Nathan Wei, MD, FACP, FACR is a rheumatologist and the arthritis treatment Center-http://www.arthritistreatmentcenter.com/. He is a former Assistant Professor of medicine, University of Maryland, University of, school of medicine and consultant to the health of the plants. For more information: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html.


View the original article here

14.41 | 0 komentar | Read More

Psoriatic Arthritis-diagnosis and treatment of Arthritis

More than 100 different types of arthritis. Term arthritis is derived from the Greek arthron, "joint", and "itis", in accordance with, in accordance with the inflammation.

In spite of this, the conditions for the accession criteria are in some of the diversity of forms, which are the common lot of arthritis than others. Examples are Rheumatoid, osteoarthritis, Gout, pseudogout, psoriatic arthritis (PA).

PA is the arthritis that occurs if the patients who also have dandruff, skin condition in increased chronic, systemic, sia, based on the characters in the form. According to the National Psoriasis Foundation at a rate of 10-30% of people with dandruff to develop the PA.

In this condition, the symptoms may be mild. However, many of the patients develop severe arthritis high stiffness, joint pain and limited on behalf of the authorities, prepared. One of the disease differing joint and tendon joints next to the involvement of emotional life. Tendon and ligament involvement may be in terms of greater than the common participation.

Tendons, which are shown in the patellar tendon is often the Achilles tendon, knee, elbow and tendon, and toes.

Patients with the PA to develop painful local swelling and toes. Prepared can be so large that the numbers look like sausages. They are sometimes referred to by the "sausage two-digit years." PA unusual, but a devastating form may be the cause of the fingers of the deformity and mutilation.

The skin is not usually difficult for dandruff, participation in the on-the-spot, even though it would be important to examine all areas, if the rash can also occur on the back of the scalp and ears, armpits, belly button, and the lymph nodes of the gluteal region.

Finger nails and toe nails can display small stones, or appear to be, in fact, lift off the nail-bed. These changes are sometimes misdiagnosed as fungus.

Systemic symptoms and signs may be present. A large percentage of patients with psoriatic arthritis develop signs of eye disease. Significant morning stiffness, lasting at least one hour, and the fatigue is also of this disease.

PA may also attack the axial skeleton-spinal column.

PA treatment is proper diagnosis and aggressive therapy. Diagnosis is suspected clinically, and may establish procedures such as magnetic imaging (MRI).

Anti-rheumatic disease modifying drugs, such as methotrexate and sulfasalazine may be useful in tendon and ligament in peripheral inflammation. In General, while the patients require cancellation of the biologic therapy. Tumor necrosis inhibitors such as Enbrel, Humira, Remicade and Simponi can be quite useful.

Nathan Wei, MD, FACP, FACR is a rheumatologist and the arthritis treatment Center-http://www.arthritistreatmentcenter.com/. He is a former Assistant Professor of medicine, University of Maryland, University of, school of medicine and consultant to the health of the plants. For more information: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html


View the original article here

03.12 | 0 komentar | Read More

What is the proper handling of the order of Arthritis

Written By Hendrafa on Kamis, 07 Februari 2013 | 16.00

Osteoarthritis (OA) is the most common form of arthritis and affects more than 20 million Americans. It's a condition that affects hyaline cartilage, the tough gristle that caps the ends of long bones.

Hyaline cartilage is a complicated material that consists of a "soup" or the matrix made up proteoglycans (complexes of proteins and sugars), grown, and chondrocytes. Chondrocytes are cartilage cells that both make as well as nourish the matrix.

When OA begins, the chondrocytes begin to make destructive enzymes causing cracks or fissures in the cartilage. These are called "fibrillations."

OA preferentially attacks weight-bearing joints such as the neck, low back, hips, and knees.

So far, the treatment of OA of the knee hasn't changed in thirty years. It remains primarily symptomatic.

Weight loss, patient education, strengthening and stretching exercise, physical therapy, assistive devices (such as braces, canes, and walkers), analgesics (pain-relieving medicines), non-steroidal anti-inflammatory drugs (NSAIDS), thermal modalities (heat and ice) are standard.

Slightly more aggressive measures such as injections with glucocorticoids ("cortisone") and viscosupplements (hyaluronic acid ... "rooster comb. shots") can be used.

However, there remains a large void because the only remaining option is knee replacement surgery.

While the technical aspects of this procedure have improved, it is still surgery with all the attendant risks of a major invasive procedure in a hospital setting. These include, infection, blood clots, the failure of the replacement, and so on. Also, most patients will need a revision procedure (a replacement of the replacement) done. And maybe more than once or twice in their lifetime.

Recently, progress in regenerative medicine procedures have provided hope that there is a n alternative to joint replacement.

Once a patient has undergone a thorough evaluation and been through the conservative treatments, consideration as to whether they may be a candidate for either rich plasma (PRP) in the platelet-should be considered. PRP is an ultraconcentrate of a may own blood that contains a high concentration of platelets, cells that contain a plethora of growth and healing factors.

Recent anecdotal reports indicating that PRP may be of benefit in alleviating symptoms in patients with OA of the knee are encouraging. PRP may be repeated as often as every three months.

In patients who have not done well with PRP, autologous mesenchymal stem cells (a may own stem cells obtained from bone marrow and fat) can be used. Small studies have shown that this treatment may both alleviate pain and restore cartilage growth. (A) the stem cell procedure is much more involved than a PRP procedure since visualization using diagnostic ultrasound and arthroscopy are needed in order to localize the area of cartilage loss and "jump start" the regenerative process by inducing injury. This induction method is what leads to the reparative process since cartilage injury and subsequent inflammation are the first stages in the healing process.

Nathan Wei, MD, FACP, FACR is a rheumatologist and Director of the Arthritis Treatment Center http://www.arthritistreatmentcenter.com/. He is a former Clinical Assistant Professor of Medicine at the University of Maryland School of Medicine and consultant to the National Institutes of Health. For more info: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html


View the original article here

16.00 | 0 komentar | Read More

Arthritis: Rheumatoid treatment of Biosimilars

Written By Hendrafa on Senin, 30 April 2012 | 00.53

Rheumatoid arthritis (RA) is one of the most common types of characters in the form. It is a systemic, chronic, progressive disorder that affects approximately, sia, two million Americans.

Although preferably attacks the joints, it can affect other body systems. These areas include, lungs, heart, skin, bone-marrow ääreishermoston, and eyes.

Early diagnosis is the key. In the case of suspicion of RA, the patient must be referred to in the rheumatologist (arthritis specialist) as soon as possible.

RA therapy, the current goal is to work with and control of the disease before the joint damage has occurred. When the diagnosis is established, an aggressive treatment should start DMARDS. These DMARDS, are usually the standard "old school" such as "the new school with DMARDS methotrexate" combination of DMARDS, called biologics (BDs). These latter drugs are proteins, which are used to focus the immune abnormalities specific to the father of the family.

This approach makes it possible to obtain a RA saw the withdrawal of the majority of patients, into account.

BDs are very complex proteins, which are much different compared to the biologic drug development process of the standard. Unlike the standard BDs is made of drugs, food proteins, antibodies or antibody. Because of this, they are very expensive, costing the edge condition, 20 000 a year in the neighborhood.

However, because the BDs are such precise "laser-targeted" weapons, they are very effective. And it is estimated that about 40% or more of patients with moderate to severe rheumatoid, take these products.

Recently, although a number of factors, including the patent expiration date and health care settings have paved the way for a "Biosimilaari" in the development of the BDs. These are essentially a generic version of the BDs, it is a good news. The Bad news is that, in the absence of the protein in the manufacture of biologic drugs is so complex, the price is expected to drop as much use of biosimilars.

Estimates vary from 60-90% of the current price, which is part of the biologic biosimilars. Cheaper but not at lower prices.

The second question is, how good they are. Because of the manufacturing process is so complex can be significant variation, so that the biosimilars may not work the same way as the original. They may also have unexpected side effects that differ from the original drugs.

In addition, the continuation of the investigation, the development of different systems for the operation of the other BDs, is expected to create a more competitive business environment. An example of some of the new oral BDs, which are expected to have a significant impact on the development of the RA development activities.

Nathan Wei, MD, FACP, FACR is a rheumatologist and the arthritis treatment Center-http://www.arthritistreatmentcenter.com/. He is a former Assistant Professor of medicine, University of Maryland, University of, school of medicine and consultant to the health of the plants. For more information: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html


View the original article here

00.53 | 0 komentar | Read More

Arthritis: Rheumatoid treatment of Biosimilars

Written By Hendrafa on Minggu, 29 April 2012 | 12.39

Rheumatoid arthritis (RA) is one of the most common types of characters in the form. It is a systemic, chronic, progressive disorder that affects approximately, sia, two million Americans.

Although preferably attacks the joints, it can affect other body systems. These areas include, lungs, heart, skin, bone-marrow ääreishermoston, and eyes.

Early diagnosis is the key. In the case of suspicion of RA, the patient must be referred to in the rheumatologist (arthritis specialist) as soon as possible.

RA therapy, the current goal is to work with and control of the disease before the joint damage has occurred. When the diagnosis is established, an aggressive treatment should start DMARDS. These DMARDS, are usually the standard "old school" such as "the new school with DMARDS methotrexate" combination of DMARDS, called biologics (BDs). These latter drugs are proteins, which are used to focus the immune abnormalities specific to the father of the family.

This approach makes it possible to obtain a RA saw the withdrawal of the majority of patients, into account.

BDs are very complex proteins, which are much different compared to the biologic drug development process of the standard. Unlike the standard BDs is made of drugs, food proteins, antibodies or antibody. Because of this, they are very expensive, costing the edge condition, 20 000 a year in the neighborhood.

However, because the BDs are such precise "laser-targeted" weapons, they are very effective. And it is estimated that about 40% or more of patients with moderate to severe rheumatoid, take these products.

Recently, although a number of factors, including the patent expiration date and health care settings have paved the way for a "Biosimilaari" in the development of the BDs. These are essentially a generic version of the BDs, it is a good news. The Bad news is that, in the absence of the protein in the manufacture of biologic drugs is so complex, the price is expected to drop as much use of biosimilars.

Estimates vary from 60-90% of the current price, which is part of the biologic biosimilars. Cheaper but not at lower prices.

The second question is, how good they are. Because of the manufacturing process is so complex can be significant variation, so that the biosimilars may not work the same way as the original. They may also have unexpected side effects that differ from the original drugs.

In addition, the continuation of the investigation, the development of different systems for the operation of the other BDs, is expected to create a more competitive business environment. An example of some of the new oral BDs, which are expected to have a significant impact on the development of the RA development activities.

Nathan Wei, MD, FACP, FACR is a rheumatologist and the arthritis treatment Center-http://www.arthritistreatmentcenter.com/. He is a former Assistant Professor of medicine, University of Maryland, University of, school of medicine and consultant to the health of the plants. For more information: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html


View the original article here

12.39 | 0 komentar | Read More

Gouty arthritis arthritis treatment: how to be handled?

Written By Hendrafa on Jumat, 06 April 2012 | 06.39

doctor arthritisGout is characterized by elevated levels of uric acid (UA) in the blood of the common metabolic disease. This is either as a result of the inability to excrete (get rid of) the UA or overproducing. In any case, what happens is, monosodium urate form within the joints of deposits and other bodies, in particular the kidneys, which are responsible for excreting large organ UA.

At a certain point in time, if a critical enough of the UA is built, gouty arthritis (GA) the attack takes place. GA, as a general rule, have joint or joints in the foot, the ankle or the knee with the foot, preferably in the attack. The attacks usually occur early in the morning, awaking, often the patient's sleep. Pain intensity is based on, and is accompanied by swelling, redness, and heat to the public. Discomfort is so severe that the patient may complain that even "the weight of the bedsheet" vulnerability in the cause unbearable pain.

The GA process is divided into General, acute and chronic disease in the attack.

Multiple options are available, and what avenue for a decision depends on a variety of factors, including, attack, duration, location of the attack, the second in the process area (ie, infection) the possibility of the presence of co-morbid conditions and other diseases, a patient is that could possibly affect the treatment of the intervention.

Medicinal products, which are treated with, Supplement, rest with the ice because ice can be useful to reduce the inflammation.

Steroidal anti-inflammatory drugs (AINS) are the most commonly used for the treatment of acute attacks. Unfortunately, these medicines, there are many possible side effects, including stomach ulcers, kidney damage, blood pressure and the risk of deterioration of the heart and line. Should be avoided in patients on blood thinners. Older workers for their use should be monitored carefully and, as far as possible, be avoided.

Colchicine is a time honored the medication that helps prevent Gout inflammation. Small doses of 0.6, two-three times per day in the mgs for 1-2 days off the attack. Colchicine has side effects that limit their use. These include Stomach cramps, nausea, vomiting, and muscle damage to bone marrow suppression, as well as the neurologic. It should not be used to pay for the patients or the kidneys.


Glucocorticoids ("Cortisone") can give directly to the common, where only one or two, or the direction or intramuscularly. Glucocorticoids are a good option when the AINS and colchicine can not be used.


By using biologic therapy for prevention of Interleukin-1 is a new concept in the treatment of acute Gout attacks. It is very effective, but the repayment is very expensive.


Nathan Wei, MD, FACP, FACR is a rheumatologist and the arthritis treatment Center-http://www.arthritistreatmentcenter.com/. He is a former Assistant Professor of medicine, University of Maryland, University of, school of medicine and consultant to the health of the plants. For more information: http://www.arthritis-treatment-and-relief.com/arthritis-treatment.html


View the original article here

06.39 | 0 komentar | Read More